Login / Signup

Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 Years.

Erez Bar-HaimNoa Eliakim-RazAmos StemmerHila CohenUri EliaAsaf NessMuhammad AwwadNassem GhantousNeta MoskovitsShahar RotemSalomon M Stemmer
Published in: Journal of clinical medicine (2022)
Both humoral and cellular anamnestic responses are significant for protective immunity against SARS-CoV-2. In the current study, the responses in elderly people before and after a fourth vaccine dose of BNT162b2 were compared to those of individuals immunized with three vaccine doses. Although a boost effect was observed, the high response following the third administration questions the necessity of an early fourth boost.
Keyphrases
  • sars cov
  • immune response
  • respiratory syndrome coronavirus